138 related articles for article (PubMed ID: 38577499)
1. Refractory facial cutaneous B-cell pseudolymphoma successfully treated with dupilumab.
Lum K; Sanchez R; Zhou C; Sangar S; Dao H; Elsensohn A
JAAD Case Rep; 2024 Apr; 46():95-99. PubMed ID: 38577499
[No Abstract] [Full Text] [Related]
2. Treatment With Dupilumab for Refractory Cutaneous B-Cell Pseudolymphoma.
Joshi TP; Duvic M; Torres-Cabala CA; Tschen J
JAMA Dermatol; 2022 Jun; 158(6):697-699. PubMed ID: 35416914
[No Abstract] [Full Text] [Related]
3. Cutaneous pseudolymphoma successfully treated with dupilumab.
Sugiura S; Nakanishi T; Fujimoto N
Eur J Dermatol; 2023 Jun; 33(3):307-309. PubMed ID: 37594345
[No Abstract] [Full Text] [Related]
4. Analysis of clonality in cutaneous B-cell lymphoma and B-cell pseudolymphoma using skin flow cytometry: Comparison of immunophenotyping and gene rearrangement studies.
Nakagawa Y; Hamada T; Takahashi T; Miyake T; Hirai Y; Iwatsuki K; Morizane S
J Dermatol; 2022 Feb; 49(2):246-252. PubMed ID: 34263482
[TBL] [Abstract][Full Text] [Related]
5. Progression of cutaneous B-cell pseudolymphoma to cutaneous B-cell lymphoma.
Kulow BF; Cualing H; Steele P; VanHorn J; Breneman JC; Mutasim DF; Breneman DL
J Cutan Med Surg; 2002; 6(6):519-28. PubMed ID: 12404039
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous B cell pseudolymphoma treated with rituximab and methotrexate.
Besch-Stokes JG; Patel MH; Brumfiel CM; Costello CM; Rule W; Rosenthal A; Pittelkow MR; DiCaudo DJ; Mangold AR
Dermatol Online J; 2021 Sep; 27(9):. PubMed ID: 34755980
[TBL] [Abstract][Full Text] [Related]
7. Plasma-cell-predominant B-cell pseudolymphoma.
Nervi SJ; Schwartz RA
Dermatol Online J; 2008 Oct; 14(10):12. PubMed ID: 19061611
[TBL] [Abstract][Full Text] [Related]
8. Differential NFATc1 Expression in Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoma and Other Forms of Cutaneous T-Cell Lymphoma and Pseudolymphoma.
Magro CM; Momtahen S
Am J Dermatopathol; 2017 Feb; 39(2):95-103. PubMed ID: 27097342
[TBL] [Abstract][Full Text] [Related]
9. HIV-related CD8+ cutaneous pseudolymphoma: efficacy of methotrexate.
Ingen-Housz-Oro S; Sbidian E; Ortonne N; Penso-Assathiany D; Chambrin V; Bagot M; Bachelez H; Wolkenstein P; Chosidow O
Dermatology; 2013; 226(1):15-8. PubMed ID: 23343593
[TBL] [Abstract][Full Text] [Related]
10. Pseudolymphoma and cutaneous lymphoma: facts and controversies.
Bergman R
Clin Dermatol; 2010; 28(5):568-74. PubMed ID: 20797521
[TBL] [Abstract][Full Text] [Related]
11. Case of immunoglobulin G4-related skin disease: possible immunoglobulin G4-related skin disease cases in cutaneous pseudolymphoma only by immunohistochemical analysis.
Iwata Y; Mizoguchi Y; Takahashi M; Tanaka B; Kuroda M; Yagami A; Matsunaga K
J Dermatol; 2013 Dec; 40(12):998-1003. PubMed ID: 24303847
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Pseudolymphoma.
Mitteldorf C; Kempf W
Surg Pathol Clin; 2017 Jun; 10(2):455-476. PubMed ID: 28477891
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous Pseudolymphoma Secondary to Facial Thread Lift Procedure.
Makhecha M; Singh T; Yadav T; Atawane M
Indian Dermatol Online J; 2019; 10(3):322-324. PubMed ID: 31149583
[TBL] [Abstract][Full Text] [Related]
14. Borrelia burgdorferi-associated lymphocytoma cutis simulating a primary cutaneous large B-cell lymphoma.
Grange F; Wechsler J; Guillaume JC; Tortel J; Tortel MC; Audhuy B; Jaulhac B; Cerroni L
J Am Acad Dermatol; 2002 Oct; 47(4):530-4. PubMed ID: 12271296
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous MALT-lymphoma: from cutaneous immunocytoma and pseudolymphoma to the current (and future) conceptions.
Fernandez-Flores A
Rom J Morphol Embryol; 2013; 54(1):7-12. PubMed ID: 23529303
[TBL] [Abstract][Full Text] [Related]
16. A case of multiple nodular cutaneous B-cell pseudolymphoma successfully treated with glucocorticoid, methotrexate, and hydroxychloroquine.
Han B; Liu H; Wang H
Dermatol Ther; 2022 Nov; 35(11):e15812. PubMed ID: 36088631
[TBL] [Abstract][Full Text] [Related]
17. [Cutaneous pseudolymphoma as an alternative presentation of IgG4 related disease].
Eddou H; Le Guyadec T; Cremades A; Saint Blancard P; Malfuson JV; Konopacki J; de Revel T
Ann Biol Clin (Paris); 2013; 71(3):333-7. PubMed ID: 23747671
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous B-cell Pseudolymphoma: A Rare Case Masquerading a Thoracic Mass in a Fourteen-Year-Old Male Patient.
Oikonomidi C; Troupi M; Marinos L; Liatsos D; Chrysikos D; Filippou D; Troupis T
Cureus; 2023 Apr; 15(4):e38003. PubMed ID: 37223157
[TBL] [Abstract][Full Text] [Related]
19. Phenytoin Induced Cutaneous B Cell Pseudolymphoma.
Riyaz N; Sasidharanpillai S; Aravindan KP; Nobin BK; Raghavan NT; Nikhila PK
Indian J Dermatol; 2015; 60(5):522. PubMed ID: 26538730
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous B-Cell Pseudolymphoma (Lymphocytoma Cutis) of the Earlobe: A Poorly Recognized Complication of Ear Piercing in Children.
Slack JC; Kurek KC; Fraulin FOG; Brundler MA
Fetal Pediatr Pathol; 2022 Jun; 41(3):486-492. PubMed ID: 33150803
[No Abstract] [Full Text] [Related]
[Next] [New Search]
